4//SEC Filing
Esperion Therapeutics, Inc. 4
Accession 0001179110-14-012600
$ESPRCIK 0001434868operating
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:06 PM ET
Size
5.4 KB
Accession
0001179110-14-012600
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2014-08-07+250,000→ 250,000 totalExercise: $15.33Exp: 2024-08-07→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]25% of option vests on August 1, 2015 and the remainder shall vest in equal quarterly installments over a three (3) year period thereafter.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001434868
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 4:06 PM ET
- Size
- 5.4 KB